
Cytek Biosciences Investor Relations Material
Latest events

Q1 2025
Cytek Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cytek Biosciences Inc
Access all reports
Cytek Biosciences Inc. is a biotechnology company specializing in cell analysis solutions. The company develops and manufactures flow cytometry instruments, reagents, and software used in biomedical research and clinical diagnostics. Cytek’s technologies enable the study of cell characteristics, functions, and biomarkers, supporting research in immunology, oncology, and other areas of life sciences. The company serves academic institutions, pharmaceutical companies, and clinical laboratories, providing tools for advanced cellular analysis and discovery. The company is headquartered in Fremont, California, and its shares are listed on the NASDAQ.
Key slides for Cytek Biosciences Inc


Investor Presentation
Cytek Biosciences Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Cytek Biosciences Inc
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
CTKB
Country
🇺🇸 United States